Trials / Unknown
UnknownNCT02822027
Intravenous Immunoglobin Transfusion in Preterm Infants With Encephalopathy of Prematurity
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
- Sex
- All
- Age
- 6 Hours
- Healthy volunteers
- Not accepted
Summary
Infection and inflammation is related to increased encephalopathy of prematurities.
Detailed description
Animal studies have verified intravenous immunoglobin can reduce brain injury. However, no studies in preterm infants were reported.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | human gamma globulin | human gamma globulin for preterm infants with encephalopathy of prematurities |
| DRUG | non-human gamma globulin | Non-human gamma globulin for preterm infants with encephalopathy of prematurities |
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-01
- First posted
- 2016-07-04
- Last updated
- 2022-10-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02822027. Inclusion in this directory is not an endorsement.